Down-regulation of FcεRI-mediated CD63 basophil response during short-term VIT determined venom-nonspecific desensitization

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Smodiš, Nina Čelesnik ^a   Šilar, Mira ^a   Eržen, Renato ^a   Rijavec, Matija ^a   Košnik, Mitja ^a   Korošec, Peter ^a  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BEE VENOM; FC EPSILON RECEPTOR 1A; FC RECEPTOR; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG;

ADULT; ANAPHYLAXIS; ANTIBODY DETECTION; ARTICLE; BASOPHIL; BEE STING; CELL ACTIVATION; CELL COUNT; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HONEYBEE; HUMAN; IMMUNOTHERAPY; MALE; MIDDLE AGED; PRICK TEST; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; UPREGULATION; VESPULA; YOUNG ADULT;

EID: 84899655716     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094762     Document Type: Article

References (36)

1. Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U (2005) EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 60: 1459-1470. (Pubitemid 41654315)
2. Bilò BM, Bonifazi F (2011) Hymenoptera venom immunotherapy. Immunotherapy 3: 229-246.
3. Bilò MB (2011) Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy 66: 35-37.
4. Forck G (1986) Insect sting provocation and skin test titration as therapy controls. Allergologie 9: S18-21. (Pubitemid 17184706)
5. Goldberg A, Confino-Cohen R (2010) Bee venom immunotherapy-how early is it effective? Allergy 65: 391-395.
6. Bussmann C, Xia J, Allam JP, Maintz L, Bieber T, et al. (2010) Early markers for protective mechanisms during rush venom immunotherapy. Allergy 65: 1558-1565.
7. C elesnik N, Vesel T, Rijavec M, S ilar M, Erzen R, et al. (2012) Short-term venom immunotherapy induces desensitization of FceRI-mediated basophil response. Allergy 67: 1594-1600.
8. Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, et al. (1999) Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-c production of T cells. J Allergy Clin Immunol 103: 326-332. (Pubitemid 29095840)
9. Novak N, Mete N, Bussmann C, Maintz L, Bieber T, et al. (2012) Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol 130: 1153-1158.
10. Nullens S, Sabato V, Faber M, Leysen J, Bridts CH, et al. (2013) Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry. Cytometry B Clin Cytom 84: 173-178.
11. Jutel M, Mü ller UR, Fricker M, Rihs S, Pichler WJ, et al. (1996) Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy 26: 1112-1118. (Pubitemid 26354358)
12. May CD, Aduna N (1971) Loss and recovery of leukocyte sensitivity to antigenic histamine release during intensive injection therapy with allergen extract. J Allergy Clin Immunol 48: 313-319.
13. May CD, Schumacher MJ, Williams CS (1972) Significance of concordant fluctuation and loss of leukocyte sensitivity to two allergens during injection therapy with one nonspecific desensitization. J Allergy Clin Immunol 50: 99-108
14. May CD, Williams CS (1973) Further studies of concordant fluctuation in sensitivity of peripheral leucocytes to unrelated allergens and the meaning of nonspecific 'densensitization'. Clin Allergy 3: 319-337.
15. Kosnik M, Wraber-Herzog B, S ilar M, Grmek-Kosnik I (2003) Rush hymenoptera venom immunotherapy modulates mast cell and basophil function. Allergy hypersensitivity asthma 1: 33-37.
16. Sobotka AK, Dembo M, Goldstein B, Lichtenstein LM (1979) Antigen-specific desensitization of human basophils. J Immunol 122: 511-517.
17. MacGlashan DW Jr, Lichtenstein LM (1981) The transition from specific to nonspecific desensitization in human basophils. J Immunol 127: 2410-2414. (Pubitemid 12245829)
18. Korosec P, Valenta R, Mittermann I, C elesnik N, Erzen R, et al. (2011) Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy. J Allergy Clin Immunol 128: 671-673.
19. Mittermann I, Zidarn M, S ilar M, Markovic-Housley Z, Aberer W, et al. (2010) Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol 125: 1300-1307.
20. Z itnik SE, Vesel T, Avcin T, S ilar M, Kosnik M, et al. (2012) Monitoring honeybee venom immunotherapy in children with the basophil activation test. Pediatr Allergy Immunol 23: 166-172
21. Erzen R, Kosnik M, S ilar M, Korosec P (2012) Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study. Allergy 67: 822-830.
22. Korosec P, S ilar M, Erzen R, C elesnik N, Bajrović N, et al. (2013) Clinical Routine Utility of Basophil Activation Testing for Diagnosis of Hymenoptera-Allergic Patients with Emphasis on Individuals with Negative Venom-Specific IgE Antibodies. Int Arch Allergy Immunol 161: 363-368.
23. Johansson SGO, Nopp A, van Hage M, Olofsson N, Lundahl J, et al. (2005) Passive IgE-sensitization by blood transfusion. Allergy 60: 1192-1199. (Pubitemid 41153149)
24. Johansson SG, Nopp A, Oman H, Ankerst J, Cardell LO, et al. (2009) The size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair) treatment. Allergy 64: 1472-1477.
25. Glaumann S, Nopp A, Johansson SG, Rudengren M, Borres MP, et al. (2012) Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children. Allergy 67: 242-247.
26. Bieber T, Simon HU (2011) Allergen-specific immunotherapy: current concepts and future directions. Allergy 66: 709-712.
27. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102: 98-106. (Pubitemid 28323835)
28. Jutel M, Akdis CA (2011) Immunological mechanisms of allergen-specific immunotherapy. Allergy 66: 725-732.
29. Varga EM, Francis JN, Zach MS, Klunker S, Aberer W, et al. (2009) Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children. Clin Exp Allergy 39: 1353-1357.
30. Nopp A, Cardell LO, Johansson SG, Oman H (2009) CD-sens: a biological measure of immunological changes stimulated by ASIT. Allergy 64: 811-814.
31. Lalek N, Kosnik M, S ilar M, Korosec P (2010) Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy. Clin Exp Allergy 40: 1186-1193.
32. Mikkelsen S, Bibby BM, Dolberg MK, Dahl R, Hoffmann HJ (2010) Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy. Clin Mol Allergy 8: 2.
33. Plewako H, Wosińska K, Arvidsson M, Bjorkander J, Skov PS, et al. (2006) Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy. Int Arch Allergy Immunol 141: 346-353. (Pubitemid 44783905)
34. Karasuyama H, Obata K, Wada T, Tsujimura Y, Mukai K (2011) Newly appreciated roles for basophils in allergy and protective immunity. Allergy 66: 1133-1141.
35. Eckman JA, Sterba PM, Kelly D, Alexander V, Liu MC, et al. (2010) Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 125: 889-895.
36. Savage JH, Courneya JP, Sterba PM, Macglashan DW, Saini SS, et al. (2012) Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. J Allergy Clin Immunol 130: 1123-1129.